Cited by 858Cancer-related Molecular PathwaysDNA Repair MechanismsCell death mechanisms and regulation

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Open access

Agarwal, M L, Agarwal, A, Taylor, W R, Stark, G R·1995·Proceedings of the National Academy of Sciences

Open this paper in CoChat — free account

Abstract

Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.

Integrity signals

Registry

Crossref · 10.1073/pnas.92.18.8493

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911

Show all 30 references

Sorted by citations

Items 101–200 of 856

The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents III: The Effect of the Ligands on Molecular Targets Involved in Proliferation
Darnell, G. A., & Richardson, D. R. (1999) · Blood · doi:10.1182/blood.v94.2.781 · Cited by 168
Mammalian GADD34, an Apoptosis- and DNA Damage-inducible Gene
Hollander, M. C., Zhan, Q., Bae, I., & Fornace, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13731 · Cited by 166
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
Thon, N., Kreth, S., & Kreth, F. W. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s50208 · Cited by 180
Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
Gupta, A., Shah, K., Oza, M. J., & Behl, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.155 · Cited by 166
Downmodulation of TGF-α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells
Grandis, J. R., Chakraborty, A., Zeng, Q., Melhem, M. F., & Tweardy, D. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980401)69:1 · Cited by 96
Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin
Lepley, D. M., & Pelling, J. C. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199707)19:2 · Cited by 164
The role of DNA damage responses in p53 biology
Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 172
p53 Regulation of G 2 Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161
Radiation-induced effects in unirradiated cells: A review and implications in cancer
Goldberg, Z., & Lehnert, B. E. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.2.337 · Cited by 160
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
Yun, J., Chae, H., Choy, H. E., Chung, J., Yoo, H., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 155
Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling
Chen, Y., Nader, G. A., Baar, K. R., Fedele, M. J., Hoffman, E. P., & Esser, K. A. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021220 · Cited by 158
p53 represses ribosomal gene transcription
Budde, A., & Grummt, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202402 · Cited by 157
Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase
Li, X., Wang, G., Zhao, J., Ding, H., Cunningham, C., Chen, F., Flynn, D. C., Reed, E., & Li, Q. Q. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5027-1 · Cited by 155
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo
Ramachandran, I., Thavathiru, E., Ramalingam, S., Natarajan, G., Mills, W. K., Benbrook, D. M., Zuna, R. E., Lightfoot, S. A., Reis, A., Anant, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.455 · Cited by 161
Aurora A, Meiosis and Mitosis
Crane, R. F., Gadea, B. B., Littlepage, L. E., Wu, H., & RUDERMAN, J. V. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2003.09.008 · Cited by 154
Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines
Tolis, C., Peters, G. J., Ferreira, C. G., Pinedo, H. M., & Giaccone, G. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00425-0 · Cited by 155
Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1
Benzeno, S., Narla, G., Allina, J., Cheng, G. Z., Reeves, H. L., Banck, M. S., Odin, J. A., Diehl, J. A., Germain, D., & Friedman, S. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2818 · Cited by 150
Tumor suppressor p53: regulation and function
Somasundaram, K. (2000) · Frontiers in bioscience · doi:10.2741/somasund · Cited by 155
Human p53 Binds Holliday Junctions Strongly and Facilitates Their Cleavage
Lee, S., Cavallo, L. M., & Griffith, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7532 · Cited by 152
Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1
Ball, K. L., Laı́n, S., Fåhræus, R., Smythe, C., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00029-7 · Cited by 156
Molecular Prognostic Markers in Pancreatic Cancer
Coppola, D. (2000) · Cancer Control · doi:10.1177/107327480000700504 · Cited by 153
Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor
Wang, Q., Zambetti, G. P., & Suttle, D. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.389 · Cited by 152
The dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 154
p53 accumulates but is functionally impaired when DNA synthesis is blocked
Gottifredi, V., Shieh, S.-Y., Taya, Y., & Prives, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1036 · Cited by 147
Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein
Munakata, T., Liang, Y., Kim, S., McGivern, D. R., Huibregtse, J. M., Nomoto, A., & Lemon, S. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030139 · Cited by 151
Functional Interaction of p53 and BLM DNA Helicase in Apoptosis
Wang, X. W., Tseng, A., Ellis, N. A., Spillare, E. A., Linke, S. P., Robles, A. I., Seker, H., Yang, Q., Hu, P., Beresten, S. F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103298200 · Cited by 145
Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts
Baus, F., Gire, V., Fisher, D., Piette, J., & Dulić, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg387 · Cited by 143
Control of E2F activity by p21Waf1/Cip1
Delavaine, L., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202923 · Cited by 143
Molecular responses of human muscle to eccentric exercise
Chen, Y.-W., Hubal, M. J., Hoffman, E. P., Thompson, P. D., & Clarkson, P. M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01161.2002 · Cited by 144
RETRACTED: Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G1 arrest via the ATM/p53 pathway
Chang, J. W., Kang, S. U., Shin, Y. S., Kim, K., Seo, S. J., Yang, S. S., Lee, J.-S., Moon, E., Baek, S. J., Lee, K., et al. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.01.022 · Cited by 140
Retracted
Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade
Nakamura, N., Yamamoto, H., Yao, T., Oda, Y., Nishiyama, K.-I., Imamura, M., Yamada, T., Nawata, H., & Tsuneyoshi, M. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.03.012 · Cited by 139
Cytotoxicity Evaluation of Oxidized Single-Walled Carbon Nanotubes and Graphene Oxide on Human Hepatoma HepG2 cells: An iTRAQ-Coupled 2D LC-MS/MS Proteome Analysis
Yuan, J., Gao, H., Sui, J., Duan, H., Chen, W. N., & Ching, C. B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr332 · Cited by 138
The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.
Shen, Z., Wen, X. F., Lan, F., Shen, Z. Z., & Shao, Z. M. (2002) · PubMed · Cited by 138
Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing
Wang, Z., Kang, W.-T., Li, O., Qi, F., Wang, J., You, Y., He, P., Suo, Z., Zheng, Y., & Liu, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.005 · Cited by 141
Characterization of p53 and p21 Functional Interactions in Glioma Cells en Route to Apoptosis
Gomez‐Manzano, C., Fueyo-Margareto, J., Kyritsis, A. P., Steck, P. A., Levin, V. A., Yung, W. K. A., & McDonnell, T. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.14.1036 · Cited by 135
Review: ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia
Lavin, M. F. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 137
Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation
Beamish, H., Williams, R. T., Chen, P., & Lavin, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20486 · Cited by 137
EF24 Induces G2/M Arrest and Apoptosis in Cisplatin-resistant Human Ovarian Cancer Cells by Increasing PTEN Expression
Selvendiran, K., Tong, L., Vishwanath, S., Bratasz, A., Trigg, N. J., Kutala, V. K., Hideg, K., & Kuppusamy, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703796200 · Cited by 136
C-myc overexpression and p53 loss cooperate to promote genomic instability
Yin, X.-Y., Grove, L. E., Datta, N. S., Long, M. W., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202410 · Cited by 136
Stabilization of p53 Is Involved in Quercetin-Induced Cell Cycle Arrest and Apoptosis in HepG2 Cells
TANIGAWA, S., FUJII, M., & HOU, D.-X. (2008) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70680 · Cited by 135
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
Sivaraman, L., Conneely, O. M., Medina, D., & O’Malley, B. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221459098 · Cited by 135
The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism
Ghorbani, A., Nazari, M., Jeddi‐Tehrani, M., & Zand, H. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0187-2 · Cited by 135
Circadian clocks, epigenetics, and cancer
Masri, S., Kinouchi, K., & Sassone‐Corsi, P. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000153 · Cited by 137
The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon, R. Y. C., Chau, M. S., Yamashita, K., & Hunter, T. R. (1997) · PubMed · Cited by 132
The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase
Passer, B. J., Nancy-Portebois, V., Amzallag, N., Prieur, S., Cans, C., de Climens, A. R., Fiucci, G., Bouvard, V., Tuynder, M., Susini, L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530298100 · Cited by 134
Oncogenic Potential of Hepatitis C Virus Proteins
Banerjee, A. K., Ray, R. B., & Ray, R. (2010) · Viruses · doi:10.3390/v2092108 · Cited by 126
Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A
Arima, N., Kao, C., Licht, T., Padmanabhan, R., Sasaguri, Y., & Padmanabhan, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008329200 · Cited by 121
p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice
Eymin, B., Leduc, C., Coll, J., Brambilla, E. M., & Gazzéri, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206303 · Cited by 117
Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest
Zuo, Z., Dean, N. M., & Honkanen, R. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12250 · Cited by 119
Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G2/M arrest or apoptosis
Yang, X., Li, D., Chen, W., & Xu, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204817 · Cited by 119
Centrosomes and cancer
Salisbury, J. L., Whitehead, C. M., Lingle, W. L., & Barrett, S. L. (1999) · Biology of the Cell · doi:10.1016/s0248-4900(99)80086-0 · Cited by 119
p53 and Cell Cycle Effects After DNA Damage
Senturk, E., & Manfredi, J. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_4 · Cited by 115
Metals and Disorders of Cell Accumulation: Modulation of Apoptosis and Cell Proliferation
Waalkes, M. P. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.2.255 · Cited by 118
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects
Behrend, L., Milne, D., Stöter, M., Deppert, W., Campbell, L. E., Meek, D. W., & Knippschild, U. (2000) · Oncogene · doi:10.1038/sj.onc.1203939 · Cited by 118
Synergy between the Mos/Mitogen-Activated Protein Kinase Pathway and Loss of p53 Function in Transformation and Chromosome Instability
Fukasawa, K., & Woude, G. F. V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.506 · Cited by 117
Nijmegen Breakage Syndrome Cells Fail To Induce the p53-Mediated DNA Damage Response following Exposure to Ionizing Radiation
Jongmans, W., Vuillaume, M., Chrzańowska, K., Smeets, D., Sperling, K., & Hall, J. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5016 · Cited by 117
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
The Paramyxovirus Simian Virus 5 V Protein Slows Progression of the Cell Cycle
Lin, G., & Lamb, R. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9152-9166.2000 · Cited by 115
Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation
Takao, N., Kato, H., Mori, R., Morrison, C. G., Sonada, E., Sun, X., Shimizu, H., Yoshioka, K., Takeda, S., & Yamamoto, K.-I. (1999) · Oncogene · doi:10.1038/sj.onc.1203172 · Cited by 109
Early endosome membrane dynamics characterized by flow cytometry
Chavrier, P., van der Sluijs, P., Mishal, Z., Nagelkerken, B., & Gorvel, J. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19970901)29:1 · Cited by 26
Use of a small molecule cell cycle inhibitor to control cell growth and improve specific productivity and product quality of recombinant proteins in CHO cell cultures
Du, Z., Treiber, D., McCarter, J. D., Fomina‐Yadlin, D., Saleem, R. A., McCoy, R. E., Zhang, Y., Tharmalingam, T., Leith, M., Follstad, B. D., et al. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25332 · Cited by 113
Molecular prognostic markers in pancreatic cancer
Ghaneh, P., Kawesha, A., Evans, J. D., & Neoptolemos, J. P. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200000 · Cited by 111
Biological functions of the ING family tumor suppressors
Campos, E. I., Chin, M. Y., Kuo, W., & Li, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4199-4 · Cited by 113
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs
Blagosklonny, M. V., Robey, R. W., Bates, S. E., & Fojo, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8625 · Cited by 112
G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford, B., Beljin, M., Stark, G. R., & Taylor, W. R. (2003) · PubMed · Cited by 109
Self-citation
p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110
Self-citation
Subcellular localisation of cyclin B, Cdc2 and p21WAF1/CIP1 in breast cancer
Winters, Z., Hunt, N., Bradburn, M. J., Royds, J. A., Turley, H., Harris, A. L., & Norbury, C. J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00327-6 · Cited by 110
A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides
Agarwal, M. L., Agarwal, A. M., Taylor, W. R., Chernova, O. B., Sharma, Y., & Stark, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14775 · Cited by 110
Self-citation
HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells
Lal, S., Burkhart, R. A., Beeharry, N., Bhattacharjee, V., Londin, E. R., Cozzitorto, J. A., Romeo, C., Jimbo, M., Norris, Z. A., Yeo, C. J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1915 · Cited by 110
Effects of Ionizing Radiation in Targeted and Nontargeted Cells
Iyer, R. S., & Lehnert, B. E. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1684 · Cited by 110
Role of p53 in Apoptosis
Canman, C. E., & Kastan, M. B. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61068-6 · Cited by 106
Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park, M., Chae, H.-D., Yun, J., Jung, M., Kim, Y. S., Kim, S., Han, M. H., & Shin, D. Y. (2000) · PubMed · Cited by 104
Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes
McVean, M., Xiao, H., Isobe, K., & Pelling, J. C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.633 · Cited by 104
Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells.
Kramer, D. L., Vujcic, S., Diegelman, P., Alderfer, J. L., Miller, J. T., Black, J. D., Bergeron, R. J., & Porter, C. W. (1999) · PubMed · Cited by 103
Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators
Kaltschmidt, B., Kaltschmidt, C., Hehner, S. P., Dröge, W., & Schmitz, M. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202657 · Cited by 102
Arsenic trioxide (As2O3) induces apoptosis and necrosis mediated cell death through mitochondrial membrane potential damage and elevated production of reactive oxygen species in PLHC-1 fish cell line
Selvaraj, V., Armistead, M. Y., Cohenford, M. A., & Murray, E. E. (2012) · Chemosphere · doi:10.1016/j.chemosphere.2012.09.039 · Cited by 101
Human lung fibroblasts prematurely senescent after exposure to ionizing radiation enhance the growth of malignant lung epithelial cells in vitro and in vivo
Kletsas, D. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1132 · Cited by 106
Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells
Sarkar, S., Brautigan, D. L., Parsons, S. J., & Larner, J. M. (2012) · Oncogene · doi:10.1038/onc.2012.561 · Cited by 99
The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells
Seegers, J. C., Lottering, M., Grobler, C. J. S., van Papendorp, D. H., Habbersett, R. C., Shou, Y., & Lehnert, B. E. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00043-5 · Cited by 99
Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development
Joseph, C., Mangani, A. S., Gupta, V. B., Chitranshi, N., Shen, T., Dheer, Y., Devaraj, K. B., Mirzaei, M., You, Y., Graham, S. L., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.0923 · Cited by 101
GADD45 Regulates G2/M Arrest, DNA Repair, and Cell Death in Keratinocytes Following Ultraviolet Exposure
Maeda, T., Hanna, A. N., Sim, A. B., Chua, P., Chong, M. T., & Tron, V. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01781.x · Cited by 96
Mortalin controls centrosome duplication via modulating centrosomal localization of p53
Ma, Z., Izumi, H., Kanai, M., Kabuyama, Y., Ahn, N. G., & Fukasawa, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209543 · Cited by 97
A novel p53‐inducible gene coding for a microtubule‐localized protein with G2‐phase‐specific expression
Utrera, R., Collavin, L., Lazarević, D., Delia, D., & Schneider, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5015 · Cited by 98
Improving cancer therapy by non-genotoxic activation of p53
Laı́n, S., & Lane, D. P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00063-7 · Cited by 99
Tumor Suppressors, Chromosomal Instability, and Hepatitis C Virus–Associated Liver Cancer
McGivern, D. R., & Lemon, S. M. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092202 · Cited by 99
Intercellular adhesions as determinants of tissue assembly and malignant invasion
Steinberg, M. S., & Foty, R. A. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2 · Cited by 43
Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt–Mdm2–p53 pathway
Rogulski, K. R., Li, Y., Rothermund, K. D., Pu, L., Watkins, S. C., Yi, F., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208897 · Cited by 96
The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair in p53 deficient human fibroblasts
Fitch, M. E., Cross, I. V., Turner, S. J., Adimoolam, S., Lin, C., Williams, K. G., & Ford, J. M. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00066-1 · Cited by 104
Folate Deficiency Induces a Cell Cycle-Specific Apoptosis in HepG2 Cells
Huang, R.-F. S., Ho, Y.-H., Lin, H.-L., Wei, J., & Liu, T. (1999) · Journal of Nutrition · doi:10.1093/jn/129.1.25 · Cited by 96
Apigenin causes G2/M arrest associated with the modulation of p21Cip1 and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells
Choi, E. J., & Kim, G. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.03.005 · Cited by 95
Taxol-induced cell cycle arrest and apoptosis: dose–response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition
Das, G. C., Holiday, D. B., Gallardo, R., & Haas, C. D. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00404-9 · Cited by 95
The Human Myoepithelial Cell Exerts Antiproliferative Effects on Breast Carcinoma Cells Characterized by p21WAF1/CIP1Induction, G2/M Arrest, and Apoptosis
Shao, Z., Nguyen, M. T. N., Alpaugh, M. L., O’Connell, J. T., & Barsky, S. H. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4066 · Cited by 95
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation
Shukla, S., Bjerke, G. A., Muhlrad, D., Yi, R., & Parker, R. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.010 · Cited by 94
Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis
Ficazzola, M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1271 · Cited by 93
Radiation and the G 2 Phase of the Cell Cycle
Hwang, A., & Muschel, R. J. (1998) · Radiation Research · doi:10.2307/3579808 · Cited by 94
p53-dependent Induction of WAF1 by Heat Treatment in Human Glioblastoma Cells
Ohnishi, T., Wang, X., Ohnishi, K., Matsumoto, H., & Takahashi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14510 · Cited by 95
p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells.
Lloyd, D. R., & Hanawalt, P. C. (2000) · PubMed · Cited by 93
p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2
Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92
Self-citation
Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence
Ramachandran, I., Ganapathy, V., Gillies, E. M., Fonseca, I., Sureban, S. M., Houchen, C. W., Reis, A., & Queimado, L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.219 · Cited by 92
Cellular Protection Mechanisms against Extracellular Heme
Eskew, J. D., Vanacore, R., Sung, L., Morales, P. J. C., & Smith, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.638 · Cited by 91

Authors: Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R.
Affiliations: Cleveland Clinic (US)
ORCID: Agarwal, A
Taylor, W R
Stark, G R
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1995-08-29
Volume: 92
Issue: 18
Pages: 8493-8497
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.92.18.8493
PMC: PMC41183
OpenAlex: W2016492849
Semantic Scholar: 0dec4b0f37cb7f12a6b4023ec829754468df3935
Cited by: 858
References: 30
Citations by year: 2026: 2 · 2025: 5 · 2024: 13 · 2023: 22 · 2022: 12 · 2021: 18 · 2020: 24 · 2019: 21 · 2018: 22 · 2017: 40 · 2016: 29 · 2015: 28 · 2014: 33 · 2013: 25 · 2012: 25
FWCI: 17.64
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, G2/M checkpoint, G1/S checkpoint, cell cycle arrest, p21, cyclin-dependent kinases, mimosine, DNA damage response
MeSH terms: Cell Cycle, Cell Division, Cell Line, Fibroblasts, Gene Expression Regulation, Humans, Genes, p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks